Propel Drug-Eluting Sinus Implant Family IBUKI Cohort
NCT07546682 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-04-23
Summary
To confirm clinical safety and performance for the PROPEL family of products when used according to IFUs and standard of care in Japan.
Conditions
- Chronic Rhinosinusitis (CRS)
Interventions
- OTHER
-
None, observational standard of care study
None, observational standard of care study
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-30
- Primary Completion
- 2027-05-31
- Completion
- 2027-08-31
Countries
- Japan
Study Locations
More Related Trials
-
Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
NCT03614923 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) .
NCT07483268 ·Status: NOT_YET_RECRUITING
-
A Clinical Evaluation of PROPEL® Contour Sinus Implant
NCT04858802 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
NCT07313917 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Xiangtong TM Full Degradation Sinus Drug Stent System Prospective, Open, Single-center, Randomized Controlled Clinical Trial
NCT06669130 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dupilumab in Chinese Adult Participants With CRSwNP
NCT05878093 ·Status: COMPLETED ·Phase: PHASE3
-
Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi
NCT01946711 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparing Budesonide Via MAD or INSI Prospective Cohort Study
NCT04267042 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps
NCT06454240 ·Status: COMPLETED ·Phase: PHASE2
-
Sinopsys Lacrimal Stent Study for Patients With Chronic Sinusitis or CRS
NCT03066908 ·Status: SUSPENDED ·Phase: NA
-
Sinopsys® Lacrimal Stent Indicated for Sinus Irrigation
NCT03304951 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Steroid Nasal Implants Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis
NCT03729310 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant
NCT06163404 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of Budesonide Irrigations on Patients With Chronic Rhinosinusitis and Impact on Sinus Surgery Rates
NCT03519061 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis
NCT01955980 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of ArchSinus, NasoPore & Propel to Prevent Post-Surgical MT Lateralization and Improve Symptomatic Outcomes
NCT05156801 ·Status: UNKNOWN ·Phase: NA
-
The Long-Term Safety of Budesonide for Patients With Chronic Rhinosinusitis
NCT03584178 ·Status: UNKNOWN ·Phase: NA
-
A Prospective Single-center Cohort Study of Surgical Treatment of Chronic Rhinosinusitis
NCT06010316 ·Status: RECRUITING
-
A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps
NCT06801353 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
NCT06338995 ·Status: RECRUITING ·Phase: PHASE3
-
Immunologic Impact of Dupilumab in Patients Suffering From Asthma and Chronic Rhinosinusitis With Polyps
NCT06556264 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Steroid Delivery to the Frontal Sinus Opening With a Bioabsorbable Implant vs. a Bioabsorbable Nasal Dressing
NCT03188822 ·Status: TERMINATED ·Phase: NA
-
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) and Comorbid Asthma
NCT07436949 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Adult Japanese Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
NCT07484230 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Sinonasal Microbiome Transplant as a Therapy for Chronic Rhinosinusitis (CRS).
NCT07184684 ·Status: RECRUITING ·Phase: PHASE2/PHASE3